Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

AXIOM IMPLANT PX ?5.2 x 10.0: medical device reports filed with FDA

795 reports name it, 2021–2026. Manufacturer given most often on reports: Anthogyr. Product code DZE.

795
device reports naming the brand
0% of all MAUDE reports · about 149 a year
202
reports, 12 months to August 2026
193 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 795 reports that name the brand "AXIOM IMPLANT PX ?5.2 x 10.0" (endosseous dental implant), received between March 2021 and August 2026; the manufacturer given most often on reports is Anthogyr. Spellings of one product vary from report to report.

202 reports arrived in the 12 months to August 2026, close to the 193 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (90.4%), loss of osseointegration (8.3%) and difficult to insert (0.5%). The patient problems coded most often are fibrosis, pain and swelling/ edema. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

02447Sep 2021: 1Oct 2021: 3Nov 2021: 5Dec 2021: 72022Jan 2022: 26Feb 2022: 17Mar 2022: 2Apr 2022: 2May 2022: 0Jun 2022: 15Jul 2022: 7Aug 2022: 3Sep 2022: 11Oct 2022: 3Nov 2022: 9Dec 2022: 102023Jan 2023: 8Feb 2023: 5Mar 2023: 1Apr 2023: 4May 2023: 9Jun 2023: 12Jul 2023: 21Aug 2023: 20Sep 2023: 28Oct 2023: 15Nov 2023: 20Dec 2023: 102024Jan 2024: 11Feb 2024: 22Mar 2024: 15Apr 2024: 7May 2024: 11Jun 2024: 16Jul 2024: 3Aug 2024: 9Sep 2024: 16Oct 2024: 11Nov 2024: 13Dec 2024: 182025Jan 2025: 12Feb 2025: 15Mar 2025: 15Apr 2025: 1May 2025: 0Jun 2025: 47Jul 2025: 19Aug 2025: 26Sep 2025: 29Oct 2025: 14Nov 2025: 19Dec 2025: 162026Jan 2026: 15Feb 2026: 15Mar 2026: 14Apr 2026: 12May 2026: 9Jun 2026: 12Jul 2026: 21Aug 2026: 26

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

01072132021: 4820212022: 10520222023: 15320232024: 15220242025: 21320252026: 1242026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%795
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report100%795
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate71990.4%62.8%
Loss of osseointegration668.3%22.4%
Difficult to insertthe device was hard to insert40.5%0.4%
Fracturea broken bone40.5%1.6%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis10012.6%
Painpain, site not specified658.2%
Swelling/ edema445.5%
Inflammationinflammation435.4%
Hemorrhage/blood loss/bleeding182.3%
Numbnessnumbness111.4%
Hypersensitivity/allergic reaction60.8%
Abscessa collection of pus40.5%
Fistula20.3%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureAXIOM IMPLANT PX ?5.2 x 10.0Product code DZEAll MAUDE reports
Reports7953,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer100%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about AXIOM IMPLANT PX ?5.2 x 10.0 reports

How many FDA reports name AXIOM IMPLANT PX ?5.2 x 10.0?

795 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 202 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (90.4%), loss of osseointegration (8.3%), difficult to insert (0.5%) and fracture (0.5%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that AXIOM IMPLANT PX ?5.2 x 10.0 was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.